Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:15:12 EST Mon 11 Nov 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
Q:SLNO
- SOLENO THERAPEUTICS INC -
http://www.soleno.life
09:15:12 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
SLNO
- Q
4.0
56.52
·
59.49
0.1
57.05
0.4
22
5
58.9799 21.38
08:04:47
Nov 06
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - All 5 today
More trades...
Time ET
Ex
Price
Change
Volume
08:04:47
Q
59.49
2.44
1
08:04:30
Q
59.56
2.51
2
08:04:30
Q
59.56
2.51
100
08:04:30
Q
59.50
2.45
100
08:04:14
Q
59.79
2.74
1
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-11-06 16:05
U:SLNO
News Release
200
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
2024-10-28 08:00
U:SLNO
News Release
200
Soleno Therapeutics to Participate in Upcoming November Investor Conferences
2024-10-21 08:00
U:SLNO
News Release
200
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
2024-10-08 08:30
U:SLNO
News Release
200
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
2024-09-16 16:05
U:SLNO
News Release
200
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
2024-08-27 08:00
U:SLNO
News Release
200
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
2024-08-19 16:17
U:SLNO
News Release
200
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-08-15 08:00
U:SLNO
News Release
200
Soleno Therapeutics Announces Updates to its Board of Directors
2024-08-07 16:05
U:SLNO
News Release
200
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
2024-06-28 08:00
U:SLNO
News Release
200
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
2024-06-24 17:18
U:SLNO
News Release
200
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-06-04 08:00
U:SLNO
News Release
200
Soleno Therapeutics Set to Join Russell 3000(TM) Index
2024-05-22 16:05
U:SLNO
News Release
200
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
2024-05-22 08:00
U:SLNO
News Release
200
Soleno Therapeutics to Participate in Upcoming Investor Conferences
2024-05-15 08:00
U:SLNO
News Release
200
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
2024-05-09 16:05
U:SLNO
News Release
200
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
2024-05-02 22:32
U:SLNO
News Release
200
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
2024-05-02 16:02
U:SLNO
News Release
200
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
2024-04-30 08:00
U:SLNO
News Release
200
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
2024-04-29 08:00
U:SLNO
News Release
200
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)